Taro Pharmaceutical (TARO) Reports Q2 Loss, Misses Revenue Estimates

Published on 21 Oct 2022 on Zacks · via Yahoo Finance

Taro (TARO) delivered earnings and revenue surprises of -108.33% and 18.96%, respectively, for the...

Read the rest of the article

Start tracking your investments with Statfolio

Insightful Analysis of Brandes Investment Partners' Latest 13F Filing Brandes Investment Partners...

GuruFocus.com · via Yahoo Finance 21 Aug 2024

(Bloomberg) -- Hand sanitizers were tainted by benzene. Sunscreens and dry shampoos too. Now acne...

Bloomberg via Yahoo Finance 7 Mar 2024

New Haven, Conn.-based Valisure, the testing laboratory that filed Tuesday’s petition and uncover...

The Boston Globe 6 Mar 2024

Amicus Therapeutics, Inc.’s FOLD lead drug, Galafold (migalastat), is the first and only approved...

Zacks via Yahoo Finance 29 Dec 2023

Senti Biosciences, Inc. SNTI announced that the FDA has cleared its investigational new drug (IND...

Zacks via Yahoo Finance 26 Dec 2023

Sanofi SNY announced that it is ending the development of the cancer program called tusamitamab r...

Zacks via Yahoo Finance 22 Dec 2023

(Bloomberg) -- The surprise attack on Israel by Hamas weighed on shares of global companies with ...

Bloomberg via Yahoo Finance 9 Oct 2023

Long term investing works well, but it doesn't always work for each individual stock. We don't wi...

Simply Wall St. via Yahoo Finance 18 Apr 2023

Taro (TARO) delivered earnings and revenue surprises of -108.33% and 18.96%, respectively, for th...

Zacks · via Yahoo Finance 21 Oct 2022

We think intelligent long term investing is the way to go. But along the way some stocks are goin...

Simply Wall St. via Yahoo Finance 12 Oct 2022